Royal Bank of Canada
EVGN icon

Royal Bank of Canada’s Evogene EVGN Stock Holding History

Royal Bank of Canada’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
42
– – ﹤0.01% 7279
2025
Q4 		$0 Hold
42
– – ﹤0.01% 7285
2025
Q3 		$0 Hold
42
– – ﹤0.01% 7231
2025
Q2 		$0 Hold
42
– – ﹤0.01% 7107
2025
Q1 		$0 Hold
42
– – ﹤0.01% 6928
2024
Q4 		$0 Hold
42
– – ﹤0.01% 6974
2024
Q3 		$0 Sell
42
-4
-9% -$17 ﹤0.01% 7007
2024
Q2 		$0 Buy
46
+42
+1,050% +$293 ﹤0.01% 7185
2024
Q1 		$0 Hold
4
– – ﹤0.01% 7159
2023
Q4 		$0 Hold
4
– – ﹤0.01% 7244
2023
Q3 		$0 Hold
4
– – ﹤0.01% 7209
2023
Q2 		$0 Sell
4
-358
-99% -$2.42K ﹤0.01% 7364
2023
Q1 		$2K Buy
362
+358
+8,950% +$2.67K ﹤0.01% 6767
2022
Q4 		$0 Sell
4
-13
-76% -$92 ﹤0.01% 7355
2022
Q3 		$0 Hold
17
– – ﹤0.01% 7552
2022
Q2 		$0 Hold
17
– – ﹤0.01% 7461
2022
Q1 		$0 Sell
17
-72
-81% -$971 ﹤0.01% 7811
2021
Q4 		$1K Sell
89
-8,027
-99% -$182K ﹤0.01% 7495
2021
Q3 		$214K Buy
8,116
+11
+0.1% +$321 ﹤0.01% 5103
2021
Q2 		$277K Sell
8,105
-46
-0.6% -$1.8K ﹤0.01% 4783
2021
Q1 		$411K Buy
8,151
+1,501
+23% +$92.9K ﹤0.01% 4357
2020
Q4 		$312K Buy
6,650
+3,840
+137% +$135K ﹤0.01% 4513
2020
Q3 		$112K Buy
+2,810
New +$50.2K ﹤0.01% 4897
2020
Q2 		– Sell
-1,000
Closed -$12K – 6694
2020
Q1 		$12K Hold
1,000
– – ﹤0.01% 5758
2019
Q4 		$15K Hold
1,000
– – ﹤0.01% 5981
2019
Q3 		$16K Hold
1,000
– – ﹤0.01% 5588
2019
Q2 		$16K Hold
1,000
– – ﹤0.01% 5806
2019
Q1 		$18K Hold
1,000
– – ﹤0.01% 5694
2018
Q4 		$20K Hold
1,000
– – ﹤0.01% 5582
2018
Q3 		$31K Buy
1,000
+500
+100% +$14.4K ﹤0.01% 5454
2018
Q2 		$14K Buy
+500
New +$15.2K ﹤0.01% 5699
2017
Q4 		– Sell
-100
Closed -$4K – 6626
2017
Q3 		$4K Buy
+100
New +$4.76K ﹤0.01% 6457

Other funds holding EVGN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada's EVGN Position: Q1 2026 in Review

Royal Bank of Canada held its Evogene (EVGN) position steady in Q1 2026 at 42 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7279.

Royal Bank of Canada first reported a position in EVGN in Q3 2017 and has held it in 32 quarters since. The position peaked at $411K in Q1 2021. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

  • Royal Bank of Canada held 42 shares of Evogene worth $0 as of Q1 2026.
  • Royal Bank of Canada left its Evogene share count unchanged in Q1 2026.
  • Evogene made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7279 holding.
  • Royal Bank of Canada first reported a position in Evogene in Q3 2017 and has held it in 32 quarters since.
  • Royal Bank of Canada's Evogene position peaked at $411K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.